Tone mix
Week by week 52 weeks
Share of CRISPR Therapeutics AG's 173 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Apr 13, 2026 · tone +992 Billion Reasons to Love CRISPR Therapeutics Right Now+79
- Week of Apr 20, 2026 · tone +100Positive Long-Term Outlook for Crispr Therapeutics as Gene Editing Portfolio Makes Progress+74
- Week of Jul 27, 2026 · tone +99Morgan Stanley Nearly Doubled Its Price Target for CRISPR Therapeutics. Is the Gene-Editing Stock a No-Brainer Buy?+67
- Week of Jul 13, 2026 · tone +993 Reasons to Buy CRISPR Therapeutics Stock+66
- Week of Nov 17, 2025 · tone +99Crispr Therapeutics gains amid takeover speculation (CRSP:NASDAQ)+61
- Week of Jun 22, 2026 · tone +99Why CRISPR Therapeutics Stock Has Been on a Roller-Coaster Ride This Year+60
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about CRISPR Therapeutics AG in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 4 | -17 |
| Last 30 sessions | 23 | +22 |
| Last 90 sessions | 53 | +30 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Wednesday, October 28, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletAvalo Therapeutics (NASDAQ:AVTX) and CRISPR Therapeutics (NASDAQ:CRSP) Critical ContrastNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Avalo Therapeutics (NASDAQ:AVTX) and CRISPR Therapeutics (NASDAQ:CRSP) Critical Contrast | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
3 headlines, average tone -23: 0 positive, 2 neutral and 1 negative. Showing all 3.
- www.fool.com · 1 outletForget Casgevy: CRISPR Therapeutics' Heart-Disease Data Could Matter MoreNegative
- www.themarketsdaily.com · 1 outletArrowhead Pharmaceuticals (NASDAQ:ARWR) and CRISPR Therapeutics (NASDAQ:CRSP) Financial ReviewNeutral
- www.themarketsdaily.com · 1 outletNTV Asset Management LLC Acquires 61,443 Shares of CRISPR Therapeutics AG $CRSPNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Forget Casgevy: CRISPR Therapeutics' Heart-Disease Data Could Matter More | www.fool.com | 1 | Negative |
| Arrowhead Pharmaceuticals (NASDAQ:ARWR) and CRISPR Therapeutics (NASDAQ:CRSP) Financial Review | www.themarketsdaily.com | 1 | Neutral |
| NTV Asset Management LLC Acquires 61,443 Shares of CRISPR Therapeutics AG $CRSP | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 20, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- seekingalpha.com · 1 outletStocks to watch after hours: AGNC, WAL, and CRSPNeutral
- www.manilatimes.net · 1 outletCRISPR Therapeutics Announces Chief Financial Officer TransitionNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Stocks to watch after hours: AGNC, WAL, and CRSP | seekingalpha.com | 1 | Neutral |
| CRISPR Therapeutics Announces Chief Financial Officer Transition | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 19, 2026
3 headlines, average tone +33: 1 positive, 2 neutral and 0 negative. Showing all 3.
- www.aol.com · 3 outletsWhere Will CRISPR Therapeutics Stock Be in 2030?Neutral
- www.fool.com · 2 outletsCathie Wood Bought More CRISPR Therapeutics Stock 2 Days in a Row. Here's What She Sees in the Biotech Stock.Positive
- www.themarketsdaily.com · 1 outletInsider Selling: CRISPR Therapeutics (NASDAQ:CRSP) General Counsel Sells $51,230.40 in StockNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Where Will CRISPR Therapeutics Stock Be in 2030? | www.aol.com | 3 | Neutral |
| Cathie Wood Bought More CRISPR Therapeutics Stock 2 Days in a Row. Here's What She Sees in the Biotech Stock. | www.fool.com | 2 | Positive |
| Insider Selling: CRISPR Therapeutics (NASDAQ:CRSP) General Counsel Sells $51,230.40 in Stock | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 12, 2026
2 headlines, average tone +50: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.fool.com · 1 outletCiti Sees 60% Upside in CRISPR Therapeutics. Here's What Has to Go Right.Positive
- www.tickerreport.com · 1 outletReviewing Aprea Therapeutics (NASDAQ:APRE) & CRISPR Therapeutics (NASDAQ:CRSP)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Citi Sees 60% Upside in CRISPR Therapeutics. Here's What Has to Go Right. | www.fool.com | 1 | Positive |
| Reviewing Aprea Therapeutics (NASDAQ:APRE) & CRISPR Therapeutics (NASDAQ:CRSP) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about CRISPR Therapeutics AG, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.